Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc

Bullboard Posts

Comment by Jo1987on May 13, 2020 2:20am

103 Views

Post# 31020607

RE:RE:RE:What's going on here?

Thanks @Jermiah, that doesn't sound so bad indeed. I do however think that it would be advantageous for the company and actually the duty of IR to at least give a little update/life sign once every 6 weeks at least. Especially in these difficult times where businesses are crumbling left and right. I think that the eroding SP is also at least to some degree a result of this lack of information. The trading volume has dried up entirely.

Bullboard Posts

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity